Grapefruit USA, Inc. (GPFT)
Grapefruit USA, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, down 50.00% on the session, giving a market capitalisation of $71,740. On trailing twelve-month figures it carries a trailing P/E of -0.33, a net margin of 0.0%. Its beta of -0.03 implies it has historically moved less than the broad market.
Grapefruit USA, Inc. is a company dedicated to the creation and distribution of cannabis-related goods, primarily serving the California market. A key offering from the firm is Hourglass, a topical cream featuring a sustained-release blend of THC and CBD, which is exclusively sold via its online platform. The business, originally established in 2017, was formerly recognized as Grapefruit Boulevard Investments, Inc., before officially adopting its current name, Grapefruit USA, Inc., in January 2020. Its main operational base is situated in Wilmington, Delaware.
Grapefruit USA, Inc. is most often compared with the following Healthcare names: